112 related articles for article (PubMed ID: 9381440)
21. Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
Ngeow WC; Chai WL; Rahman RA; Ramli R
Singapore Dent J; 2006 Dec; 28(1):1-3. PubMed ID: 17378333
[TBL] [Abstract][Full Text] [Related]
22. Chewing gum and a saliva substitute alleviate thirst and xerostomia in patients on haemodialysis.
Bots CP; Brand HS; Veerman EC; Korevaar JC; Valentijn-Benz M; Bezemer PD; Valentijn RM; Vos PF; Bijlsma JA; ter Wee PM; Van Amerongen BM; Nieuw Amerongen AV
Nephrol Dial Transplant; 2005 Mar; 20(3):578-84. PubMed ID: 15665029
[TBL] [Abstract][Full Text] [Related]
23. A randomized study to assess the effectiveness of orally administered pilocarpine during and after radiotherapy of head and neck cancer.
Nyárády Z; Németh A; Bán A; Mukics A; Nyárády J; Ember I; Olasz L
Anticancer Res; 2006; 26(2B):1557-62. PubMed ID: 16619571
[TBL] [Abstract][Full Text] [Related]
24. Assessment of xerostomia and its impact on quality of life in head and neck cancer patients undergoing radiotherapy, and validation of the Taiwanese version of the xerostomia questionnaire.
Lin SC; Jen YM; Chang YC; Lin CC
J Pain Symptom Manage; 2008 Aug; 36(2):141-8. PubMed ID: 18395402
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of a novel lubricating system in the management of radiotherapy-related xerostomia.
McMillan AS; Tsang CS; Wong MC; Kam AY
Oral Oncol; 2006 Sep; 42(8):842-8. PubMed ID: 16455288
[TBL] [Abstract][Full Text] [Related]
26. The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy.
Kong L; Lu JJ; Hu C; Guo X; Wu Y; Zhang Y
Cancer; 2006 Sep; 107(6):1287-93. PubMed ID: 16909425
[TBL] [Abstract][Full Text] [Related]
27. The effect of acupuncture on salivary flow rates in patients with radiation-induced xerostomia.
Braga FP; Sugaya NN; Hirota SK; Weinfeld I; Magalhães MH; Migliari DA
Minerva Stomatol; 2008; 57(7-8):343-8. PubMed ID: 18784633
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced xerostomia.
Chambers MS; Rosenthal DI; Weber RS
Head Neck; 2007 Jan; 29(1):58-63. PubMed ID: 16906511
[TBL] [Abstract][Full Text] [Related]
29. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
30. Nasopharyngeal carcinoma in childhood and adolescence: a single institution's experience with treatment modalities during the last 15 years.
Polychronopoulou S; Kostaridou S; Panagiotou JP; Stefanaki K; Papadakis V; Florentin L; Houlakis M; Christopoulos G; Haidas S
Pediatr Hematol Oncol; 2004; 21(5):393-402. PubMed ID: 15205082
[TBL] [Abstract][Full Text] [Related]
31. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
[TBL] [Abstract][Full Text] [Related]
32. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
[TBL] [Abstract][Full Text] [Related]
33. Oral medicine case book 53: radiation-induced xerostomia.
Cheung TY; Peck MT; Dreyer WP
SADJ; 2013 Sep; 68(8):376, 378, 380. PubMed ID: 24660406
[No Abstract] [Full Text] [Related]
34. The role of saliva in oral health: strategies for prevention and management of xerostomia.
Brosky ME
J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
[TBL] [Abstract][Full Text] [Related]
35. Grading xerostomia by physicians or by patients after intensity-modulated radiotherapy of head-and-neck cancer.
Meirovitz A; Murdoch-Kinch CA; Schipper M; Pan C; Eisbruch A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):445-53. PubMed ID: 16839705
[TBL] [Abstract][Full Text] [Related]
36. Epidural metastasis in nasopharyngeal carcinoma.
Bagatzounis A; Erakleous E; Michaelides I
Strahlenther Onkol; 2003 Feb; 179(2):123-8. PubMed ID: 12590324
[TBL] [Abstract][Full Text] [Related]
37. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial.
Wasserman TH; Brizel DM; Henke M; Monnier A; Eschwege F; Sauer R; Strnad V
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):985-90. PubMed ID: 16253773
[TBL] [Abstract][Full Text] [Related]
38. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma.
Lee SW; Back GM; Yi BY; Choi EK; Ahn SD; Shin SS; Kim JH; Kim SY; Lee BJ; Nam SY; Choi SH; Kim SB; Park JH; Lee KK; Park SH; Kim JH
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):152-60. PubMed ID: 16472934
[TBL] [Abstract][Full Text] [Related]
39. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
